Cytokine Release Syndrome Clinical Trial
Official title:
Prediction for Systemic Inflammation With Clinical Scoring Systems and Inflammatory Cytokine Levels in Adult Cardiac and Major Abdominal Surgical Patients
Cardiac surgery with cardiopulmonary bypass (CPB) and hepatic surgery are major operations, associated with a systemic inflammatory response syndrome. The aim of this study is to assess the effectiveness of clinical scoring systems and inflammatory cytokine levels for predicting systemic inflammation. This correlation might identify peri-operative clinical outcomes, then forecast further systemic inflammation in cardiac and hepatic surgical patients.
Status | Completed |
Enrollment | 20 |
Est. completion date | December 2010 |
Est. primary completion date | October 2010 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - adult patients who had undergone elective cardiac surgery with CPB Exclusion Criteria: - under 18 years of age - needing emergency surgery - needing intra-aortic balloon pump |
Observational Model: Case-Only, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Thailand | Queen Sirikit Heart Center of the Northeast, Khon Kaen University | Khon Kaen |
Lead Sponsor | Collaborator |
---|---|
Khon Kaen University |
Thailand,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Correlation of clinical scoring systems and inflammatory cytokine levels | Blood samples were collected sequentially at 0, 0.5, 4, 12, and 24 h after CPB for cytokines [Interleukin (IL)-6, IL-8, and IL-10] investigation and leukocyte counts. Clinical scoring systems [Acute Physiology and Chronic Health Evaluation (APACHE) II, Sequential Organ Failure Assessment (SOFA) and Multi-Organ Dysfunction (MOD)] were calculated and recorded at each time point. Correlations were assessed. | 24 h after CPB | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03685383 -
Cytokine Adsorption in Post-cardiac Arrest Syndrome in Patients Requiring Extracorporeal Cardiopulmonary Resuscitation
|
N/A | |
Terminated |
NCT04540120 -
Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome
|
Phase 2 | |
Terminated |
NCT03557749 -
Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies
|
||
Active, not recruiting |
NCT04150913 -
A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity
|
Phase 2 | |
Completed |
NCT04643678 -
Anakinra in the Management of COVID-19 Infection
|
Phase 2/Phase 3 | |
Recruiting |
NCT04975555 -
Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy
|
Phase 2 | |
Terminated |
NCT04403685 -
Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers
|
Phase 3 | |
Completed |
NCT04366908 -
Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome
|
Phase 2 | |
Completed |
NCT05349669 -
Jafron Haemoadsorption During Cardiopulmonary Bypass
|
Phase 2 | |
Completed |
NCT04720378 -
Safety and Tolerability Study of IV ST266 in COVID-19 Subjects
|
Phase 1 | |
Terminated |
NCT04415073 -
A Phase 2 Study to Evaluate Axatilimab for Hospitalized Participants With Respiratory Involvement Secondary to COVID-19
|
Phase 2 | |
Completed |
NCT03533101 -
Tocilizumab for Cytokine Release Syndrome Prophylaxis in Haploidentical Transplantation
|
Phase 1/Phase 2 | |
Completed |
NCT04403061 -
Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of Outcome
|
||
Recruiting |
NCT05414162 -
Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy
|
||
Completed |
NCT04475588 -
Efficacy and Safety of Itolizumab in COVID-19 Complications
|
Phase 2 | |
Terminated |
NCT04377503 -
Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19
|
Phase 2 | |
Recruiting |
NCT04781803 -
Cyclosporine on Day Zero as Prophylaxis for Cytokine Release Syndrome
|
Phase 2 | |
Completed |
NCT04048525 -
Cytokine Removal With CVVHD Compared to CVVH
|
N/A | |
Recruiting |
NCT04048434 -
Extracorporeal Cytokine Adsorption as Additive Treatment of CAR-T Associated Cytokine Release Syndrome (CRS)
|
N/A | |
Recruiting |
NCT04486521 -
Anti-IL6 and Corticosteroid Monotherapy vs Combination in COVID-19
|